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Dear Editor,
We read with interest the online issue of Archives of
Gynecology and Obstetrics of December 2009, Roy et al.
[1] present a retrospective study on the effect of hystero-
scopic septal resection for women with a history of
recurrent miscarriages, preterm deliveries and infertility.
The authors conclude that hysteroscopic metroplasty is a
safe and effective procedure to improve obstetric outcome
in these women. Unfortunately the interpretation of the
results of this study has been subjected to a methodological
pitfall.
This study, amongst many others evaluating the efficacy
of hysteroscopic metroplasty, compares reproductive out-
come in women before and after surgery, using these
women as their own controls. This is not a fair comparison
since the very reason for performing the surgery has been
the poor reproductive outcome in the index pregnancy.
These women could have miscarried by chance and still
have a good chance of conceiving and having a live birth
without any treatment. Making these before–after com-
parison will always favor the intervention [2, 3]. Therefore,
we cannot agree with the conclusions of Roy et al. [1].
The only way to evaluate the efficacy of hysteroscopic
metroplasty in women with recurrent miscarriage is to
perform a randomized controlled trial. We disagree with
the comments of Roy et al. that performing such a trial
would not be possible due to ethical reasons.
In our opinion, it is unethical to perform treatment
without the knowledge of the effectiveness of this treat-
ment. We have recently launched the TRUST trial (The
Randomized Uterine Septum Transsection trial: NTR1676)
that randomizes women with recurrent miscarriage
between hysteroscopic metroplasty and expectant man-
agement. The results of this trial will answer the question,
whether hysteroscopic metroplasty is a safe and effective
method for improving reproductive outcome. Roy et al. are
warmly invited to participate in our study.
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